<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20447" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Diabetic Perioperative Management</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dogra</surname>
            <given-names>Prerna</given-names>
          </name>
          <aff>University of Kentucky</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Anastasopoulou</surname>
            <given-names>Catherine</given-names>
          </name>
          <aff>Jefferson Einstein Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jialal</surname>
            <given-names>Ishwarlal</given-names>
          </name>
          <aff>VA MEDICAL CENTER, MATHER , CA</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Prerna Dogra declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Catherine Anastasopoulou declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ishwarlal Jialal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>1</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20447.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The effective management of diabetes during the perioperative period is essential, given the increasing prevalence of diabetes mellitus and the subsequent rise in surgical procedures among individuals with diabetes. Maintaining optimal diabetes control before, during, and after any surgical procedure is paramount for preventing complications.&#x000a0;In both diabetic and non-diabetic populations, hyperglycemia during the perioperative period serves as an independent marker of adverse surgical outcomes. In addition, hyperglycemia&#x000a0;elevates morbidity and mortality risks, including delayed wound healing, an increased rate of infection, ICU admissions, prolonged hospital stays, and higher postoperative mortality.</p>
        <p>The stress induced by surgery, anesthesia, and illness leads to heightened secretion of counterregulatory hormones, such as cortisol, glucagon, growth hormone, and catecholamines. Consequently, this process reduces insulin secretion and peripheral&#x000a0;glucose utilization, elevates insulin resistance, and increases lipolysis and proteolysis.&#x000a0;This activity focuses on using&#x000a0;diverse antidiabetic medicines, introduces strategies to achieve optimal glycemic targets, and underscores the significance of an interprofessional healthcare team approach in delivering care to diabetic patients during the perioperative period. This activity also provides healthcare professionals with the essential knowledge and tools to deliver optimal care for individuals with diabetes mellitus undergoing surgical procedures.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify diabetic patients at risk by recognizing key factors, such as type of diabetes, glycemic control, and susceptibility to hypoglycemia, during preoperative assessment.</p></list-item><list-item><p>Assess the effectiveness of diverse antidiabetic medications and glycemic targets in preventing complications.</p></list-item><list-item><p>Apply standardized protocols and algorithms to ensure accurate and timely adjustments to insulin regimens, considering individual patient needs.</p></list-item><list-item><p>Collaborate with the interprofessional healthcare team to ensure coordinated and comprehensive care for diabetic patients throughout the perioperative period.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20447&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20447">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20447.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Due to the increasing prevalence of diabetes mellitus and the&#x000a0;subsequent rise in surgical procedures among individuals with diabetes, the&#x000a0;effective management of the condition&#x000a0;during the perioperative period is essential. Maintaining optimal diabetes control before, during, and after any surgical procedure is paramount for preventing complications.&#x000a0;In both diabetic and non-diabetic populations, hyperglycemia during the perioperative period serves as an independent marker of adverse surgical outcomes. In addition, hyperglycemia&#x000a0;elevates morbidity and mortality risks, including delayed wound healing, an increased rate of infection, intensive care unit (ICU) admissions, prolonged hospital stays, and higher postoperative mortality.<xref ref-type="bibr" rid="article-20447.r1">[1]</xref><xref ref-type="bibr" rid="article-20447.r2">[2]</xref><xref ref-type="bibr" rid="article-20447.r3">[3]</xref><xref ref-type="bibr" rid="article-20447.r4">[4]</xref> Hyperglycemia, defined as blood glucose levels exceeding 140 mg/dL, is a common phenomenon, with a prevalence ranging from 20% to 40% in general surgery and reaching 80% to 90% in the cardiac surgery population.<xref ref-type="bibr" rid="article-20447.r2">[2]</xref><xref ref-type="bibr" rid="article-20447.r4">[4]</xref><xref ref-type="bibr" rid="article-20447.r5">[5]</xref><xref ref-type="bibr" rid="article-20447.r6">[6]</xref></p>
        <p>The stress induced by surgery, anesthesia, and illness leads to heightened secretion of counterregulatory hormones, such as cortisol, glucagon, growth hormone, and catecholamines.<xref ref-type="bibr" rid="article-20447.r7">[7]</xref> Consequently, this process reduces insulin secretion and peripheral&#x000a0;glucose utilization, elevates insulin resistance, and increases lipolysis and proteolysis. As a result, gluconeogenesis and glycogenolysis increase, which results in the exacerbation of hyperglycemia, commonly referred to as stress hyperglycemia.</p>
        <p>Uncontrolled hyperglycemia triggers osmotic diuresis, leading to fluid and electrolyte imbalance, ketogenesis, and heightened production of proinflammatory cytokines. This, in turn, results in mitochondrial injury, endothelial dysfunction, and immune dysregulation.<xref ref-type="bibr" rid="article-20447.r8">[8]</xref><xref ref-type="bibr" rid="article-20447.r9">[9]</xref> Hence, maintaining optimal glucose control in the perioperative period is associated with favorable postoperative outcomes.<xref ref-type="bibr" rid="article-20447.r4">[4]</xref><xref ref-type="bibr" rid="article-20447.r5">[5]</xref></p>
      </sec>
      <sec id="article-20447.s3" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>
<bold>Perioperative Management</bold>
</p>
        <p>Various societies provide guidelines for optimal glucose management in the perioperative period.</p>
        <list list-type="bullet">
          <list-item>
            <p>The American Diabetes Association (ADA) recommends&#x000a0;a target blood glucose range of 80 to 180 mg/dL in the perioperative period and 140 to 180 mg/dL&#x000a0;for critically ill patients.<xref ref-type="bibr" rid="article-20447.r10">[10]</xref>.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>The Society for Ambulatory Anesthesia recommends maintaining intraoperative blood glucose levels less than 180&#x000a0;mg/dL for patients undergoing ambulatory surgery.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>The Society of Critical Care Medicine recommends initiating insulin therapy for critically ill patients with blood glucose levels above 150 mg/dL.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>The American College of Physicians advises against using intensive insulin therapy and recommends a blood glucose target of 140 to 200 mg/dL.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>The Society of Thoracic Surgeons advocates maintaining intraoperative blood glucose levels below 180 mg/dL and keeping them lower than 110 mg/dL in the pre-meal or fasting state.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>The Endocrine Society recommends pre-meal glucose targets less than 140&#x000a0;mg/dL&#x000a0;and random glucose levels lower than 180&#x000a0;mg/dL&#x000a0;in non-critically ill hospitalized patients. In addition, the Endocrine Society also&#x000a0;outlines that a higher target of glucose of under 200 mg/dL&#x000a0;is acceptable in non-critically ill hospitalized patients with a terminal illness, limited life expectancy, or at high risk for hypoglycemia.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>The Joint British Diabetes Societies recommend blood glucose levels of 108 to 180 mg/dL for most patients, with an acceptable range between 72 and 216 mg/dL.</p>
          </list-item>
        </list>
        <p>Although the optimal glycemic target in perioperative patients is not definitively established, a reasonable goal is maintaining blood glucose levels between 140&#x000a0;and 180 mg/dL to prevent hypoglycemia and hyperglycemia. The perioperative period is divided into 3 phases&#x02014;preoperative, intraoperative, and postoperative.<xref ref-type="bibr" rid="article-20447.r11">[11]</xref></p>
        <p>
<bold>Preoperative phase:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>History:&#x000a0;Before surgery, it is important to gather a comprehensive medical history of the patient, focusing on the below-mentioned conditions.
<list list-type="bullet"><list-item><p>Diabetes mellitus: Information regarding the type of diabetes, management of the condition (lifestyle modifications and medications), current glycemic control, related complications (nephropathy, neuropathy, retinopathy, and cardiovascular diseases), susceptibility to hypoglycemia (blood glucose levels less than 70 mg/dL) and hypoglycemia unawareness should be obtained from the patient. For individuals on antidiabetic drugs, it is imperative to understand the details of the regimen and medication adherence.<xref ref-type="bibr" rid="article-20447.r12">[12]</xref></p></list-item><list-item><p>Surgery: Details should be obtained about any surgery that the patient underwent, including whether it was ambulatory or inpatient, elective, time-sensitive, or emergent. In addition, the anticipated duration of the surgery and fasting instructions should be obtained.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Glycated hemoglobin A1c: A preoperative hemoglobin A1c (HbA1c) should be checked if not tested in the preceding 3 months. Numerous studies have examined the association between HbA1c and surgical outcomes. Based on existing literature, it remains controversial whether elevated HbA1c is linked to poor postoperative outcomes or is merely a marker of poor perioperative glucose control.<xref ref-type="bibr" rid="article-20447.r13">[13]</xref><xref ref-type="bibr" rid="article-20447.r14">[14]</xref><xref ref-type="bibr" rid="article-20447.r15">[15]</xref><xref ref-type="bibr" rid="article-20447.r16">[16]</xref><xref ref-type="bibr" rid="article-20447.r17">[17]</xref>&#x000a0;Nevertheless, obtaining a preoperative HbA1c is recommended to assess glycemic control and identify patients with undiagnosed diabetes.<xref ref-type="bibr" rid="article-20447.r18">[18]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Oral antihyperglycemic and non-insulin injectable medication: Safety and efficacy concerns arise regarding using oral antihyperglycemic and non-insulin injectables in perioperative or hospital settings.
<list list-type="bullet"><list-item><p>Metformin, in particular, may contribute to the development of lactic acidosis in cases of renal dysfunction.</p></list-item><list-item><p>Sulfonylureas and other insulin secretagogues pose a risk of hypoglycemia, especially when combined with intravenous contrast.</p></list-item><list-item><p>Sodium-glucose cotransporter-2 (SGLT-2) inhibitors carry the risk of euglycemic ketoacidosis in fasting or acutely ill patients.</p></list-item><list-item><p>Glucagon-like peptide-1 receptor (GLP-1) agonists can worsen nausea and vomiting by delaying gastric emptying.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>The recommendation is to discontinue these medications on the day of surgery, except for SGLT-2 inhibitors,<xref ref-type="bibr" rid="article-20447.r19">[19]</xref><xref ref-type="bibr" rid="article-20447.r20">[20]</xref>&#x000a0;which should be&#x000a0;discontinued 24 to 72 hours before surgery.<xref ref-type="bibr" rid="article-20447.r21">[21]</xref><xref ref-type="bibr" rid="article-20447.r22">[22]</xref><xref ref-type="bibr" rid="article-20447.r23">[23]</xref>&#x000a0;These medications should be stopped immediately for emergency surgery or illness.</p>
        <p>Recent evidence from randomized controlled trials (RCTs), including the SITA-HOSPITAL trial, has demonstrated that dipeptidyl peptidase-4 (DPP-4) inhibitors are safe and efficacious in medical and surgical patients with mild-to-moderate hyperglycemia.<xref ref-type="bibr" rid="article-20447.r24">[24]</xref><xref ref-type="bibr" rid="article-20447.r25">[25]</xref><xref ref-type="bibr" rid="article-20447.r26">[26]</xref> However, it is noteworthy that recent guidelines published by the ADA do not recommend using DPP-4 inhibitors in the inpatient setting.</p>
        <p>There is an emerging interest regarding GLP-1 agonists&#x000a0;in the hospital setting, and multiple large RCTs are currently underway.<xref ref-type="bibr" rid="article-20447.r27">[27]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Insulin therapy: When administering insulin at home, it is recommended to make titrations to the treatment as mentioned below.
<list list-type="bullet"><list-item><p>Patients on home insulin therapy should decrease the dose of long-acting basal insulin (glargine and detemir) from 20% to 25% the evening before surgery.<xref ref-type="bibr" rid="article-20447.r28">[28]</xref> If&#x000a0;they routinely take basal insulin only in the morning, the reduced dose should instead be administered on the morning of surgery.</p></list-item><list-item><p>Patients on twice-daily glargine or detemir should reduce the dose by 20% to 25% the evening before the morning of surgery and on the morning of surgery.</p></list-item><list-item><p>Patients who administer high doses of basal insulin (&#x0003e;60% of total daily dose (TDD) of insulin), have a&#x000a0;TDD&#x000a0;of insulin exceeding 80 units, or have a&#x000a0;high risk of hypoglycemia (eg, older populations, those with renal or hepatic insufficiency, or those with a history of hypoglycemic episodes) should reduce their basal insulin dose by 50% to 75% to minimize the risk of hypoglycemia.</p></list-item><list-item><p>In cases of intermediate-acting insulin such as neutral protamine Hagedorn (NPH), the usual dose is administered the evening prior and reduced by 50% on the morning of surgery.</p></list-item><list-item><p>Patients using premixed insulin (NPH/regular 70/30 or aspart protamine/aspart 75/25) should preferably receive long-acting insulin the evening before surgery instead of their premixed formulation. In situations where this is not feasible, the premixed insulin should be reduced by 50% on the morning of surgery, and dextrose-containing intravenous solutions should be initiated. Another option for these patients is to skip the morning dose and arrive early at the preoperative area to receive a long-acting formulation before surgery (see&#x000a0;<bold>Image.</bold>&#x000a0;Preoperative Insulin Adjustments).</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>During fasting, nutritional (or prandial) insulin is withheld, and subcutaneous correctional insulin is initiated with blood glucose monitoring every 4 to 6 hours. Many institutions have standardized correctional insulin scales based on various insulin sensitivities (see&#x000a0;<bold>Image.</bold>&#x000a0;Correctional Insulin Scale).<xref ref-type="bibr" rid="article-20447.r29">[29]</xref></p>
        <p>Continuous intravenous infusion (CII) with regular insulin is the preferred regimen for critically ill patients. Intravenous insulin is preferable in hemodynamic instability, hypothermia, or peripheral vasoconstriction, where subcutaneous insulin absorption is poor, given its more predictable pharmacokinetics. In addition, intravenous insulin facilitates easy dose titration due to its shorter duration of action (10 to 15 minutes) and eliminates the need for multiple injections. The utilization of CII should adhere to a validated institutional protocol, encompassing a standardized approach for infusion preparation, initiation, titration, and monitoring.<xref ref-type="bibr" rid="article-20447.r30">[30]</xref></p>
        <p>Patients with diabetes should be scheduled for surgery early in the day. In addition, it is recommended to check blood glucose levels in the preoperative area before any surgery. If hyperglycemic or hypoglycemic in the preoperative area, treatment should be attempted before surgery. Hypoglycemia treatment may involve glucose tablets, gels, or intravenous dextrose solutions. In cases of severe hyperglycemia (blood glucose levels exceeding 250 mg/dL) or metabolic decompensation (diabetic ketoacidosis or hyperglycemic hyperosmolar syndrome), it is prudent to consider postponing surgery until improved glycemic control is achieved.</p>
        <p><bold>Intraoperative phase:</bold> Hyperglycemia during surgeries of shorter duration (less than 4 hours) with anticipated hemodynamic stability and minimal fluid shifts can be addressed by administering subcutaneous correctional insulin (preferably rapid-acting insulin) every 2 hours, along with regular blood glucose checks.&#x000a0;For surgeries involving significant hemodynamic fluctuations, extensive fluid shifts, or lasting longer than 4 hours, blood glucose levels exceeding 180 mg/dL should be managed with intravenous insulin infusion, and blood glucose should be monitored every 1 to 2 hours.</p>
        <p><bold>Postoperative phase:&#x000a0;</bold>In the post-anesthesia care unit (PACU), it is imperative to review intraoperative hyperglycemia management and continue close glucose monitoring with either intravenous or subcutaneous insulin.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Ambulatory patients:&#x000a0;After recovery in the PACU, ambulatory surgery patients who are stable and can tolerate oral intake can be discharged home while continuing their previous antihyperglycemic regimen.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Non-critically ill patients:&#x000a0;Non-critically ill patients who require hospitalization&#x000a0;are transferred from the PACU to the surgical or medical ward and administered subcutaneous insulin. The preferred insulin regimen for patients with poor or no oral intake is basal plus correctional insulin.<xref ref-type="bibr" rid="article-20447.r31">[31]</xref> In cases where patients have regular oral nutrition, the insulin regimen should include basal, nutritional, and correctional components.
<list list-type="bullet"><list-item><p>Basal insulin: This controls hyperglycemia during periods when a patient is not eating (such as at night, between meals, or during fasting) and can be administered as long-acting insulin (such as glargine or detemir) once or twice daily.</p></list-item><list-item><p>Nutritional insulin: This is also referred to as meal-time or prandial insulin, and it assists in managing hyperglycemia associated with carbohydrate intake from meals, enteral, or parenteral nutrition. This can be achieved with either rapid-acting insulin (such as lispro, aspart, or glulisine) or short-acting insulin (regular).</p></list-item><list-item><p>Correctional insulin: This is used to counteract hyperglycemia that exceeds the targeted levels and utilizes either rapid-acting or short-acting insulin. The formulations are combined into a single dose when correctional insulin is administered alongside nutritional insulin.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>The insulin dosage can be adjusted based on either weight or pre-hospitalization regimen. For weight-based dosing, the following insulin regimen is observed for patients:</p>
        <list list-type="bullet">
          <list-item>
            <p>In an average patient, the TDD of insulin is usually 0.4 to 0.5 U/kg/day.</p>
          </list-item>
          <list-item>
            <p>For insulin-sensitive patients, including those with type 1 diabetes, insulin-na&#x000ef;ve individuals, older populations, or those with renal or hepatic insufficiency and frequent hypoglycemia,<xref ref-type="bibr" rid="article-20447.r32">[32]</xref>&#x000a0;the starting dose should be reduced to 0.2 from 0.3 U/kg/day.</p>
          </list-item>
          <list-item>
            <p>In insulin-resistant patients (individuals with obesity or on high-dose steroids), the starting dose should be increased from 0.6 to 0.7 U/kg/day.</p>
          </list-item>
          <list-item>
            <p>If a patient exhibits features belonging to both insulin-sensitive and insulin-resistant categories, it is advisable to dose as insulin-sensitive for safety.</p>
          </list-item>
        </list>
        <p>Once the TDD is determined, half of the TDD will be administered as basal insulin, and 1/6 of the TDD will be administered as nutritional insulin with each of the 3 meals.<xref ref-type="bibr" rid="article-20447.r33">[33]</xref><xref ref-type="bibr" rid="article-20447.r34">[34]</xref> During meals, blood glucose is typically monitored four times a day (before meals and at bedtime), and correctional insulin is administered accordingly. For patients receiving nothing by mouth, blood glucose should be monitored every 6 hours for correction with regular insulin or every 4 hours for correction with rapid-acting insulin.</p>
        <list list-type="bullet">
          <list-item>
            <p>Critically ill patients: Critically ill patients should be addressed in a medical or surgical ICU with CII, bypassing PACU. Regular insulin should be used, with blood glucose monitoring every 1 to 2 hours. The transition from CII to long or intermediate-acting subcutaneous insulin is undertaken once these patients achieve hemodynamic stability with no vasopressor requirement, exhibit optimal glycemic control with minimal variability, and maintain a steady infusion rate for the past 6 to 8 hours. In addition, it is essential to overlap intravenous and subcutaneous insulin by 2 to 3 hours due to the extremely short half-life of intravenous insulin and the delayed onset of action of long or intermediate-acting insulin. Premature discontinuation of intravenous insulin creates a&#x000a0;hiatus in the basal insulin supply, posing a risk of rebound hyperglycemia or metabolic decompensation, particularly in individuals with type 1 diabetes.</p>
          </list-item>
        </list>
        <p>When transitioning from CII, subcutaneous basal insulin is dosed based on either the calculation of insulin infusion rate, weight-based, or home insulin dose.</p>
        <list list-type="bullet">
          <list-item>
            <p>Rate of insulin infusion: When using the rate of infusion method to calculate the basal insulin dose, the average rate over the last 6 to 8 hours gets extrapolated to 24 hours. Around 70% to 80% of this extrapolated dose represents TDD. In a patient with minimal or no caloric intake, 100% of the calculated TDD is administered as basal. In contrast, in patients with optimal caloric intake, 50% is given as basal and 50% as nutritional insulin.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Weight-based: In the weight-based method, TDD is calculated similarly to non-critically ill patients, with half of it designated as a basal dose and the remaining half as nutritional insulin.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Home insulin dose: In patients with well-maintained glycemic control on home insulin therapy, 70% to 80% of the home basal insulin dose can be administered during the transition. When a patient transitions to subcutaneous, they require correctional insulin to manage hyperglycemia. This insulin should be administered every 4 to 6 hours if the patient is fasting and 4 times a day (before meals and at bedtime) if the patient is eating. This is true for non-critically ill patients.<xref ref-type="bibr" rid="article-20447.r35">[35]</xref><xref ref-type="bibr" rid="article-20447.r36">[36]</xref></p>
          </list-item>
        </list>
        <p>Due to unpredictable glycemic fluctuations, relying solely on correctional insulin is not recommended.<xref ref-type="bibr" rid="article-20447.r37">[37]</xref><xref ref-type="bibr" rid="article-20447.r38">[38]</xref> Furthermore, premixed insulin regimens should be avoided in the perioperative setting due to the increased risk of hypoglycemia.<xref ref-type="bibr" rid="article-20447.r39">[39]</xref> The use of oral or non-insulin antihyperglycemic agents is an area of active research and is presently not recommended for glucose management in these patients.<xref ref-type="bibr" rid="article-20447.r10">[10]</xref></p>
        <p>Nearly all patients will necessitate ongoing adjustments to their insulin regimen based on blood glucose levels, nutritional intake, and changes in clinical status. When making adjustments, glucose trends are more crucial than individual blood glucose readings.</p>
      </sec>
      <sec id="article-20447.s4" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>In critically ill patients, several RCTs, such as the NICE-SUGAR (Normoglycemia in Intensive Care Evaluation&#x02013;Survival Using Glucose Algorithm Regulation) study, have compared conventional glucose control, which is &#x0003c;180 mg/dL, with intensive glucose control, which is 81 to 108 mg/dL. The results are noteworthy for a higher incidence of severe hypoglycemia and increased mortality in patients subjected to intensive glucose control.<xref ref-type="bibr" rid="article-20447.r5">[5]</xref><xref ref-type="bibr" rid="article-20447.r40">[40]</xref><xref ref-type="bibr" rid="article-20447.r41">[41]</xref><xref ref-type="bibr" rid="article-20447.r42">[42]</xref><xref ref-type="bibr" rid="article-20447.r43">[43]</xref> However, the absence of RCTs in non-critically ill patients necessitates extrapolating data from studies conducted on critically ill individuals.&#x000a0;</p>
      </sec>
      <sec id="article-20447.s5" sec-type="Other Issues">
        <title>Other Issues</title>
        <p>
<bold>Type 1 Diabetes</bold>
</p>
        <p>As individuals with type 1 diabetes have minimal to no pancreatic beta-cell function, they require a continuous basal supply of insulin at all times, either subcutaneously or intravenously, even when fasting. Failure to provide this basal insulin can lead to decompensation into diabetic ketoacidosis.<xref ref-type="bibr" rid="article-20447.r44">[44]</xref></p>
        <p>
<bold>Subcutaneous Insulin Pumps</bold>
</p>
        <p>In recent years, the utilization of insulin pumps has experienced exponential growth, particularly in type 1 diabetes. However, using insulin pumps in the hospital setting during the pre- and postoperative periods must adhere to clear institutional policies and the patient's ability to manage the pump.<xref ref-type="bibr" rid="article-20447.r45">[45]</xref><xref ref-type="bibr" rid="article-20447.r46">[46]</xref> Continuing insulin pump use intraoperatively should be limited to procedures lasting fewer than 2 hours in coordination with the anesthesiology provider.<xref ref-type="bibr" rid="article-20447.r47">[47]</xref>&#x000a0;Recent studies demonstrate better glycemic control, as indicated by longer time-in-range glucose levels, with insulin pumps, and this is achieved without an associated increase in hypoglycemia or ketosis rates.<xref ref-type="bibr" rid="article-20447.r48">[48]</xref>&#x000a0;Insulin pumps provide basal coverage with a continuous subcutaneous infusion of small doses of rapid-acting insulin.</p>
        <p>Nutritional and correctional bolus coverage is achieved by manually dispensing the required dose of rapid-acting insulin through a button on the insulin pump. If it becomes impractical to continue using the pump, these patients should transition to a subcutaneous basal-bolus regimen.<xref ref-type="bibr" rid="article-20447.r49">[49]</xref>&#x000a0;Furthermore, it is recommended to administer basal insulin at least 2 hours before discontinuing the insulin pump. This critical step helps prevent any interruption in basal insulin supply and subsequent rebound hyperglycemia or metabolic decompensation. The dose of long-acting basal insulin to be administered is equivalent to the 24-hour basal dose of insulin delivered by the pump. An alternative method involves calculating the basal requirement based on weight and individual insulin sensitivity.<xref ref-type="bibr" rid="article-20447.r50">[50]</xref></p>
        <p>
<bold>Enteral Nutrition</bold>
</p>
        <p>Diabetic patients on enteral nutrition should ideally receive formulas with low carbohydrates and high monosaturated fatty acids. Subcutaneous insulin regimens for these patients should encompass basal, nutritional, and correctional components. Typically, 30% to 50% of the TDD is administered as basal, either once or twice daily. The remaining 50% to 70% of TDD is allocated as nutritional insulin. An alternative method for calculating the dose of nutritional insulin is to administer 1 unit of rapid-acting or regular insulin for every 10 to 15 grams of carbohydrates that will be provided with each bolus feed or in 24 hours with a continuous feed.<xref ref-type="bibr" rid="article-20447.r10">[10]</xref><xref ref-type="bibr" rid="article-20447.r51">[51]</xref><xref ref-type="bibr" rid="article-20447.r52">[52]</xref> For patients receiving continuous tube feeds, nutritional and correctional insulin is administered every 4 hours (with rapid-acting insulin) or every 6 hours (with regular insulin). The nutritional and correctional insulin is given before the bolus feed.</p>
        <p>
<bold>Total Parenteral Nutrition</bold>
</p>
        <p>In patients receiving total parenteral nutrition (TPN), insulin can be provided as a separate intravenous infusion or added to the TPN solution. When added to the solution, a starting point is to add 1 unit of regular insulin for every 10 grams of dextrose, and the regimen should be adjusted every 1 to 2 days based on glycemic trends.&#x000a0;Another approach is to initiate a separate intravenous infusion initially. Once blood glucose is within the glycemic goal, 80% to 100% of the total insulin dose provided via intravenous infusion is incorporated into the TPN solution. Furthermore, blood glucose monitoring with subcutaneous correctional insulin every 4 to 6 hours addresses any hyperglycemia above the target range.<xref ref-type="bibr" rid="article-20447.r10">[10]</xref><xref ref-type="bibr" rid="article-20447.r53">[53]</xref></p>
        <p>
<bold>Hypoglycemia</bold>
</p>
        <p>Based on the classification by the International Hypoglycemia Study Group, a blood glucose level less than 70 mg/dL is the hypoglycemia alert value (level 1), a blood glucose level less than 54 mg/dL indicates clinically significant hypoglycemia (level 2), and cognitive impairment with no specific blood glucose threshold qualifies as severe hypoglycemia (level 3).<xref ref-type="bibr" rid="article-20447.r54">[54]</xref> Iatrogenic hypoglycemia is the most dangerous adverse effect of antihyperglycemic therapy and is a major limiting factor in optimizing glycemic management in diabetic patients.</p>
        <p>Iatrogenic hypoglycemia is a common occurrence in the perioperative setting and correlates to poor patient outcomes and mortality.<xref ref-type="bibr" rid="article-20447.r42">[42]</xref><xref ref-type="bibr" rid="article-20447.r55">[55]</xref> Factors contributing to hypoglycemia include inappropriately dosed insulin, aggressive glycemic targets, insulin administration not aligned with mealtime, insulin stacking, unforeseen changes in caloric intake, poor provider-provider or provider-nurse communication, and failure to recognize glycemic trends.<xref ref-type="bibr" rid="article-20447.r56">[56]</xref> Every institution should implement a hypoglycemia management protocol that entails a plan for treatment and prevention.<xref ref-type="bibr" rid="article-20447.r57">[57]</xref> Following ADA recommendations, the treatment regimen should be reviewed and, if necessary, modified when blood glucose falls below 70 mg/dL, as this often precedes imminent severe hypoglycemia.</p>
      </sec>
      <sec id="article-20447.s6" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Interprofessional communication and care coordination among physicians of various specialties, including surgeons, anesthesiologists, hospitalists, endocrinologists, and primary care providers, along with nurses, pharmacists, nutritionists, and diabetes educators, are crucial for the optimal management of diabetes in patients during the perioperative period. Effective communication helps reduce adverse events, enhance clinical outcomes, and boost patient satisfaction. Formulating a structured plan tailored to individual patient needs is essential. Standardized protocols and computerized algorithms are crucial in reducing errors and delivering quality care to this patient population.<xref ref-type="bibr" rid="article-20447.r58">[58]</xref> The patient and their family should consistently receive clear written and verbal instructions regarding modifications to the medication regimen both before and after the surgery.&#x000a0;</p>
        <p>A safe transition from the inpatient to outpatient setting is crucial for effective diabetes management. The discharge plan should include medication reconciliation, patient education conducted by a healthcare professional, such as a doctor, pharmacist, or nurse, with expertise in diabetes education, evaluation of socioeconomic issues by case managers, and communication with an outpatient provider. If the pharmacist identifies concerns during medication reconciliation, they should be discussed with the healthcare team. The diabetic nurse educator ensures that the patient and their family comprehend the outpatient management plan. Any concerns about potential misunderstandings or lapses in follow-up should be communicated to the interprofessional team before discharge.</p>
        <p>A follow-up visit with the primary care provider or endocrinologist within&#x000a0;1&#x000a0;month of discharge from the hospital is advisable for all patients. An earlier appointment within 1 to 2 weeks if a change in medication or glycemic control was not optimal at discharge is preferred. Patients should receive prescriptions, drugs, and necessary medical equipment to help bridge care with their outpatient follow-up visits, and a coordinated interprofessional strategy is the best means to achieve this.<xref ref-type="bibr" rid="article-20447.r10">[10]</xref></p>
      </sec>
      <sec id="article-20447.s7">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20447&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20447">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20447/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20447">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-20447.s8">
        <fig id="article-20447.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Preoperative Insulin Adjustments and Correctional Insulin Scale Contributed by Prerna Dogra, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Preoperative__Insulin__Adjustments__1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-20447.s9">
        <title>References</title>
        <ref id="article-20447.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kotagal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Symons</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Hirsch</surname>
                <given-names>IB</given-names>
              </name>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Dellinger</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Farrokhi</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Flum</surname>
                <given-names>DR</given-names>
              </name>
              <collab>SCOAP-CERTAIN Collaborative</collab>
            </person-group>
            <article-title>Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes.</article-title>
            <source>Ann Surg</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>261</volume>
            <issue>1</issue>
            <fpage>97</fpage>
            <page-range>97-103</page-range>
            <pub-id pub-id-type="pmid">25133932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frisch</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chandra</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Smiley</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rizzo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gatcliffe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hudson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mendoza</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery.</article-title>
            <source>Diabetes Care</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>33</volume>
            <issue>8</issue>
            <fpage>1783</fpage>
            <page-range>1783-8</page-range>
            <pub-id pub-id-type="pmid">20435798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Isaacs</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Bazargan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>You</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Thaler</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Kitabchi</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2002</year>
            <month>Mar</month>
            <volume>87</volume>
            <issue>3</issue>
            <fpage>978</fpage>
            <page-range>978-82</page-range>
            <pub-id pub-id-type="pmid">11889147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dellinger</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Yanez</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Farrohki</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Flum</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program.</article-title>
            <source>Ann Surg</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>257</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-14</page-range>
            <pub-id pub-id-type="pmid">23235393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Umpierrez</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cardona</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pasquel</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Unigwe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Newton</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Smiley-Byrd</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vellanki</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Halkos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Puskas</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Guyton</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Thourani</surname>
                <given-names>VH</given-names>
              </name>
            </person-group>
            <article-title>Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial.</article-title>
            <source>Diabetes Care</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>38</volume>
            <issue>9</issue>
            <fpage>1665</fpage>
            <page-range>1665-72</page-range>
            <pub-id pub-id-type="pmid">26180108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmeltz</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>DeSantis</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Thiyagarajan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>O'Shea-Mahler</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Henske</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Gleason</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>McGee</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Molitch</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy.</article-title>
            <source>Diabetes Care</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>823</fpage>
            <page-range>823-8</page-range>
            <pub-id pub-id-type="pmid">17229943</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Himes</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Ganesh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wight</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Simha</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Liebow</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Perioperative Evaluation and Management of Endocrine Disorders.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>95</volume>
            <issue>12</issue>
            <fpage>2760</fpage>
            <page-range>2760-2774</page-range>
            <pub-id pub-id-type="pmid">33168157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palermo</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Gianchandani</surname>
                <given-names>RY</given-names>
              </name>
              <name>
                <surname>McDonnell</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Alexanian</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Stress Hyperglycemia During Surgery and Anesthesia: Pathogenesis and Clinical Implications.</article-title>
            <source>Curr Diab Rep</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>33</fpage>
            <pub-id pub-id-type="pmid">26957107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lipshutz</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Gropper</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Perioperative glycemic control: an evidence-based review.</article-title>
            <source>Anesthesiology</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>110</volume>
            <issue>2</issue>
            <fpage>408</fpage>
            <page-range>408-21</page-range>
            <pub-id pub-id-type="pmid">19194167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <collab>American Diabetes Association</collab>
            <article-title>14. Diabetes Care in the Hospital: <italic>Standards of Medical Care in Diabetes-2018</italic>.</article-title>
            <source>Diabetes Care</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>41</volume>
            <issue>Suppl 1</issue>
            <fpage>S144</fpage>
            <page-range>S144-S151</page-range>
            <pub-id pub-id-type="pmid">29222385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palermo</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Perioperative Management of Diabetes Mellitus: Novel Approaches.</article-title>
            <source>Curr Diab Rep</source>
            <year>2019</year>
            <month>Feb</month>
            <day>26</day>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>14</fpage>
            <pub-id pub-id-type="pmid">30806818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grant</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chowdhury</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>New guidance on the perioperative management of diabetes.</article-title>
            <source>Clin Med (Lond)</source>
            <year>2022</year>
            <month>Jan</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-44</page-range>
            <pub-id pub-id-type="pmid">34921055</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Underwood</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Askari</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hurwitz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chamarthi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures.</article-title>
            <source>Diabetes Care</source>
            <year>2014</year>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>611</fpage>
            <page-range>611-6</page-range>
            <pub-id pub-id-type="pmid">24170760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Godshaw</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Ojard</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Chimento</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Mohammed</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Waddell</surname>
                <given-names>BS</given-names>
              </name>
            </person-group>
            <article-title>Preoperative Glycemic Control Predicts Perioperative Serum Glucose Levels in Patients Undergoing Total Joint Arthroplasty.</article-title>
            <source>J Arthroplasty</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>33</volume>
            <issue>7S</issue>
            <fpage>S76</fpage>
            <page-range>S76-S80</page-range>
            <pub-id pub-id-type="pmid">29576485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van den Boom</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Schroeder</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Manning</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Setji</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Fiestan</surname>
                <given-names>GO</given-names>
              </name>
              <name>
                <surname>Dunson</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Effect of A1C and Glucose on Postoperative Mortality in Noncardiac and Cardiac Surgeries.</article-title>
            <source>Diabetes Care</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>41</volume>
            <issue>4</issue>
            <fpage>782</fpage>
            <page-range>782-788</page-range>
            <pub-id pub-id-type="pmid">29440113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Halkos</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Puskas</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Lattouf</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Kilgo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kerendi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Guyton</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Thourani</surname>
                <given-names>VH</given-names>
              </name>
            </person-group>
            <article-title>Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery.</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>136</volume>
            <issue>3</issue>
            <fpage>631</fpage>
            <page-range>631-40</page-range>
            <pub-id pub-id-type="pmid">18805264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bardia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Khabbaz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mathur</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Novack</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Talmor</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Subramaniam</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>The Association Between Preoperative Hemoglobin A1C and Postoperative Glycemic Variability on 30-Day Major Adverse Outcomes Following Isolated Cardiac Valvular Surgery.</article-title>
            <source>Anesth Analg</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>124</volume>
            <issue>1</issue>
            <fpage>16</fpage>
            <page-range>16-22</page-range>
            <pub-id pub-id-type="pmid">27861432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lenk</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Whittle</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Aronson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Fuller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Setji</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Duke University Medical Center Perioperative Diabetes Management Program.</article-title>
            <source>Clin Diabetes</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>208</fpage>
            <page-range>208-214</page-range>
            <pub-id pub-id-type="pmid">33986575</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patoulias</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Manafis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mitas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Avranas</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lales</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zografou</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sambanis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Karagiannis</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis; from Pathophysiology to Clinical Practice.</article-title>
            <source>Cardiovasc Hematol Disord Drug Targets</source>
            <year>2018</year>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>139</fpage>
            <page-range>139-146</page-range>
            <pub-id pub-id-type="pmid">29412120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bardia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fontes</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Sodium-glucose cotransporter-2 inhibitors: an overview and perioperative implications.</article-title>
            <source>Curr Opin Anaesthesiol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>80</fpage>
            <page-range>80-85</page-range>
            <pub-id pub-id-type="pmid">30531609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuzulugil</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Papeix</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Luu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kerridge</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Recent advances in diabetes treatments and their perioperative implications.</article-title>
            <source>Curr Opin Anaesthesiol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>398</fpage>
            <page-range>398-404</page-range>
            <pub-id pub-id-type="pmid">30958402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nanjappa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Jesudason</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Thiruvenkatarajan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Perioperative management of sodium-glucose cotransporter-2 inhibitors: importance of a nuanced approach.</article-title>
            <source>Anaesth Intensive Care</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>424</fpage>
            <page-range>424-425</page-range>
            <pub-id pub-id-type="pmid">29966117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peacock</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Lovshin</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Cherney</surname>
                <given-names>DZI</given-names>
              </name>
            </person-group>
            <article-title>Perioperative Considerations for the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes.</article-title>
            <source>Anesth Analg</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>126</volume>
            <issue>2</issue>
            <fpage>699</fpage>
            <page-range>699-704</page-range>
            <pub-id pub-id-type="pmid">28786838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Gianchandani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Smiley</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wesorick</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Newton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Farrokhi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Reyes</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lathkar-Pradhan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pasquel</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study.</article-title>
            <source>Diabetes Care</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>36</volume>
            <issue>11</issue>
            <fpage>3430</fpage>
            <page-range>3430-5</page-range>
            <pub-id pub-id-type="pmid">23877988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pasquel</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Gianchandani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rubin</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Dungan</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Anzola</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gomez</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hodish</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bodnar</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wesorick</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Balakrishnan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Osei</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial.</article-title>
            <source>Lancet Diabetes Endocrinol</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>125</fpage>
            <page-range>125-133</page-range>
            <pub-id pub-id-type="pmid">27964837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schuman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hurwitz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Metzger</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bhandari</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients.</article-title>
            <source>BMJ Open Diabetes Res Care</source>
            <year>2017</year>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>e000394</fpage>
            <pub-id pub-id-type="pmid">28405346</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hulst</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Plummer</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Hollmann</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>DeVries</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Preckel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Deane</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Hermanides</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Systematic review of incretin therapy during peri-operative and intensive care.</article-title>
            <source>Crit Care</source>
            <year>2018</year>
            <month>Nov</month>
            <day>14</day>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>299</fpage>
            <pub-id pub-id-type="pmid">30428906</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Demma</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Carlson</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Duggan</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Morrow</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Umpierrez</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Effect of basal insulin dosage on blood glucose concentration in ambulatory surgery patients with type 2 diabetes.</article-title>
            <source>J Clin Anesth</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>36</volume>
            <fpage>184</fpage>
            <page-range>184-188</page-range>
            <pub-id pub-id-type="pmid">28183563</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r29">
          <label>29</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Rushakoff</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <chapter-title>Inpatient Diabetes Management</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Feingold</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Anawalt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Blackman</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Boyce</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chrousos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Corpas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>de Herder</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Dhatariya</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dungan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hofland</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kalra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaltsas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kapoor</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kopp</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Korbonits</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kovacs</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Kuohung</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Laferr&#x000e8;re</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McGee</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>McLachlan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>New</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Purnell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sahay</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sperling</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Stratakis</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Trence</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <source>Endotext [Internet]</source>
            <publisher-name>MDText.com, Inc.</publisher-name>
            <publisher-loc>South Dartmouth (MA)</publisher-loc>
            <year>2019</year>
            <month>1</month>
            <day>7</day>
            <pub-id pub-id-type="pmid">25905206</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacobi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bircher</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Krinsley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Agus</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Braithwaite</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Deutschman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Freire</surname>
                <given-names>AX</given-names>
              </name>
              <name>
                <surname>Geehan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kohl</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Nasraway</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Rigby</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sands</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schallom</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Umpierrez</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mazuski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schunemann</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients.</article-title>
            <source>Crit Care Med</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>40</volume>
            <issue>12</issue>
            <fpage>3251</fpage>
            <page-range>3251-76</page-range>
            <pub-id pub-id-type="pmid">23164767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Smiley</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hermayer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Olson</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Newton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rizzo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Reyes</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pinzon</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Fereira</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gore</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Toyoshima</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Fonseca</surname>
                <given-names>VA</given-names>
              </name>
            </person-group>
            <article-title>Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial.</article-title>
            <source>Diabetes Care</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>36</volume>
            <issue>8</issue>
            <fpage>2169</fpage>
            <page-range>2169-74</page-range>
            <pub-id pub-id-type="pmid">23435159</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Navaneethan</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Zoungas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Caramori</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>JCN</given-names>
              </name>
              <name>
                <surname>Heerspink</surname>
                <given-names>HJL</given-names>
              </name>
              <name>
                <surname>Hurst</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Liew</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Michos</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Olowu</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Sadusky</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tandon</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tuttle</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Wanner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wilkens</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Tunnicliffe</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Tonelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Earley</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rossing</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>de Boer</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Khunti</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update.</article-title>
            <source>Ann Intern Med</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>176</volume>
            <issue>3</issue>
            <fpage>381</fpage>
            <page-range>381-387</page-range>
            <pub-id pub-id-type="pmid">36623286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duggan</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Carlson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Perioperative Hyperglycemia Management: An Update.</article-title>
            <source>Anesthesiology</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>126</volume>
            <issue>3</issue>
            <fpage>547</fpage>
            <page-range>547-560</page-range>
            <pub-id pub-id-type="pmid">28121636</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wesorick</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>O'Malley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rushakoff</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Larsen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Magee</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Management of diabetes and hyperglycemia in the hospital: a practical guide to subcutaneous insulin use in the non-critically ill, adult patient.</article-title>
            <source>J Hosp Med</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>3</volume>
            <issue>5 Suppl</issue>
            <fpage>17</fpage>
            <page-range>17-28</page-range>
            <pub-id pub-id-type="pmid">18951381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Childers</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Maynard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Box</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Namba</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stadalman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Renvall</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Maintaining glycemic control when transitioning from infusion insulin: a protocol-driven, multidisciplinary approach.</article-title>
            <source>J Hosp Med</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>5</volume>
            <issue>8</issue>
            <fpage>446</fpage>
            <page-range>446-51</page-range>
            <pub-id pub-id-type="pmid">20945469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmeltz</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>DeSantis</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>O'Shea-Mahler</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rhee</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brandt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Molitch</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia.</article-title>
            <source>Endocr Pract</source>
            <year>2006</year>
            <season>Nov-Dec</season>
            <volume>12</volume>
            <issue>6</issue>
            <fpage>641</fpage>
            <page-range>641-50</page-range>
            <pub-id pub-id-type="pmid">17229660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Smiley</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zisman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Prieto</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Palacio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ceron</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Puig</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mejia</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).</article-title>
            <source>Diabetes Care</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>30</volume>
            <issue>9</issue>
            <fpage>2181</fpage>
            <page-range>2181-6</page-range>
            <pub-id pub-id-type="pmid">17513708</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Smiley</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Temponi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mulligan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Umpierrez</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Newton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Olson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rizzo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery).</article-title>
            <source>Diabetes Care</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>256</fpage>
            <page-range>256-61</page-range>
            <pub-id pub-id-type="pmid">21228246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bellido</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Suarez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Sanchez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dieguez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Riestra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Casal</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Delgado</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Menendez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes.</article-title>
            <source>Diabetes Care</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>38</volume>
            <issue>12</issue>
            <fpage>2211</fpage>
            <page-range>2211-6</page-range>
            <pub-id pub-id-type="pmid">26459273</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wiener</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Wiener</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Larson</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Benefits and risks of tight glucose control in critically ill adults: a meta-analysis.</article-title>
            <source>JAMA</source>
            <year>2008</year>
            <month>Aug</month>
            <day>27</day>
            <volume>300</volume>
            <issue>8</issue>
            <fpage>933</fpage>
            <page-range>933-44</page-range>
            <pub-id pub-id-type="pmid">18728267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>NICE-SUGAR Study Investigators</collab>
              <name>
                <surname>Finfer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chittock</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Blair</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dhingra</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bellomo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dodek</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Henderson</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>H&#x000e9;bert</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Heritier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Heyland</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>McArthur</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Myburgh</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Norton</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Potter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Ronco</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Intensive versus conventional glucose control in critically ill patients.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>Mar</month>
            <day>26</day>
            <volume>360</volume>
            <issue>13</issue>
            <fpage>1283</fpage>
            <page-range>1283-97</page-range>
            <pub-id pub-id-type="pmid">19318384</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Griesdale</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>de Souza</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>van Dam</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Heyland</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dhaliwal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Henderson</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Chittock</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Finfer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Talmor</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data.</article-title>
            <source>CMAJ</source>
            <year>2009</year>
            <month>Apr</month>
            <day>14</day>
            <volume>180</volume>
            <issue>8</issue>
            <fpage>821</fpage>
            <page-range>821-7</page-range>
            <pub-id pub-id-type="pmid">19318387</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schuman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bader</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hurwitz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Turchin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Underwood</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Metzger</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lortie</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Effect of Preoperative Diabetes Management on Glycemic Control and Clinical Outcomes After Elective Surgery.</article-title>
            <source>Ann Surg</source>
            <year>2018</year>
            <month>May</month>
            <volume>267</volume>
            <issue>5</issue>
            <fpage>858</fpage>
            <page-range>858-862</page-range>
            <pub-id pub-id-type="pmid">28549013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Wilpe</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hulst</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Siegelaar</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>DeVries</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Preckel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hermanides</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Type 1 and other types of diabetes mellitus in the perioperative period. What the anaesthetist should know.</article-title>
            <source>J Clin Anesth</source>
            <year>2023</year>
            <month>Feb</month>
            <volume>84</volume>
            <fpage>111012</fpage>
            <pub-id pub-id-type="pmid">36427486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Partridge</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Perkins</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mathieu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nicholls</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Adeniji</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Clinical recommendations in the management of the patient with type 1 diabetes on insulin pump therapy in the perioperative period: a primer for the anaesthetist.</article-title>
            <source>Br J Anaesth</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>116</volume>
            <issue>1</issue>
            <fpage>18</fpage>
            <page-range>18-26</page-range>
            <pub-id pub-id-type="pmid">26675948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Evans</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Insulin pumps in hospital: a guide for the generalist physician.</article-title>
            <source>Clin Med (Lond)</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>244</fpage>
            <page-range>244-7</page-range>
            <pub-id pub-id-type="pmid">23760696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simha</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Perioperative Glucose Control in Patients With Diabetes Undergoing Elective Surgery.</article-title>
            <source>JAMA</source>
            <year>2019</year>
            <month>Jan</month>
            <day>29</day>
            <volume>321</volume>
            <issue>4</issue>
            <fpage>399</fpage>
            <page-range>399-400</page-range>
            <pub-id pub-id-type="pmid">30615031</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herzig</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Suhner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Roos</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sch&#x000fc;rch</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cecchini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nakas</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kadner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kocher</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Guensch</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Wilinska</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Raabe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Siebenrock</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Beldi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gloor</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hovorka</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vogt</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Bally</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Perioperative Fully Closed-Loop Insulin Delivery in Patients Undergoing Elective Surgery: An Open-Label, Randomized Controlled Trial.</article-title>
            <source>Diabetes Care</source>
            <year>2022</year>
            <month>Sep</month>
            <day>01</day>
            <volume>45</volume>
            <issue>9</issue>
            <fpage>2076</fpage>
            <page-range>2076-2083</page-range>
            <pub-id pub-id-type="pmid">35880252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vogt</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Bally</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Perioperative glucose management: Current status and future directions.</article-title>
            <source>Best Pract Res Clin Anaesthesiol</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>213</fpage>
            <page-range>213-224</page-range>
            <pub-id pub-id-type="pmid">32711830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lansang</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Modic</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Sauvey</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lock</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Combs</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Approach to the adult hospitalized patient on an insulin pump.</article-title>
            <source>J Hosp Med</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>8</volume>
            <issue>12</issue>
            <fpage>721</fpage>
            <page-range>721-7</page-range>
            <pub-id pub-id-type="pmid">24227761</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ceriello</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Laube</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sinclair</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Engfer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stratton</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis.</article-title>
            <source>Diabetes Care</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>28</volume>
            <issue>9</issue>
            <fpage>2267</fpage>
            <page-range>2267-79</page-range>
            <pub-id pub-id-type="pmid">16123506</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Basal versus sliding-scale regular insulin in hospitalized patients with hyperglycemia during enteral nutrition therapy.</article-title>
            <source>Diabetes Care</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>751</fpage>
            <page-range>751-3</page-range>
            <pub-id pub-id-type="pmid">19336641</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pichardo-Lowden</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Gabbay</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Management of hyperglycemia in the non-intensive care patient: featuring subcutaneous insulin protocols.</article-title>
            <source>Endocr Pract</source>
            <year>2011</year>
            <season>Mar-Apr</season>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>249</fpage>
            <page-range>249-60</page-range>
            <pub-id pub-id-type="pmid">21041168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <collab>International Hypoglycaemia Study Group</collab>
            <article-title>Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.</article-title>
            <source>Diabetes Care</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>155</fpage>
            <page-range>155-157</page-range>
            <pub-id pub-id-type="pmid">27872155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Devanesan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lloyd</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Samad</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Saha</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Glycaemic control in intensive care: Everything in moderation.</article-title>
            <source>J Intensive Care Soc</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>280</fpage>
            <page-range>280-283</page-range>
            <pub-id pub-id-type="pmid">28979511</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mustafa</surname>
                <given-names>OG</given-names>
              </name>
              <name>
                <surname>Choudhary</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Hypoglycaemia in hospital: a preventable killer?</article-title>
            <source>Diabet Med</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>31</volume>
            <issue>10</issue>
            <fpage>1151</fpage>
            <page-range>1151-2</page-range>
            <pub-id pub-id-type="pmid">24975637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kulasa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Juang</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>How Low Can You Go? Reducing Rates of Hypoglycemia in the Non-critical Care Hospital Setting.</article-title>
            <source>Curr Diab Rep</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>9</issue>
            <fpage>74</fpage>
            <pub-id pub-id-type="pmid">28755062</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20447.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Draznin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gilden</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Golden</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Inzucchi</surname>
                <given-names>SE</given-names>
              </name>
              <collab>PRIDE investigators</collab>
              <name>
                <surname>Baldwin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bode</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Boord</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Braithwaite</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Cagliero</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dungan</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Falciglia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Figaro</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Hirsch</surname>
                <given-names>IB</given-names>
              </name>
              <name>
                <surname>Klonoff</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Korytkowski</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Kosiborod</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lien</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Magee</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Masharani</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Maynard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>McDonnell</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Moghissi</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Rasouli</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rubin</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Rushakoff</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Sadhu</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Seley</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Vigersky</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Low</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Wexler</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action.</article-title>
            <source>Diabetes Care</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>36</volume>
            <issue>7</issue>
            <fpage>1807</fpage>
            <page-range>1807-14</page-range>
            <pub-id pub-id-type="pmid">23801791</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
